Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome

Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):666-668. doi: 10.1093/ehjcvp/pvad029.

¹ Maria Cecilia Hospital, GVM Care & Research, Via Corriera, 1, 48033 Cotignola, Ravenna, Italy.
² Department of Advanced Biomedical Sciences, University Federico II of Naples, Corso Umberto I 40, 80138 Naples, Italy.
³ Department of Internal Medicine (Di.M.I.), University of Genoa, Italy, Viale Benedetto XV, 6, 16132 Genoa, Italy.
⁴ Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.
⁵ Division of Cardiology, University of Florida College of Medicine, 655 West 8th Street, Jacksonville, FL 32209, USA.

No abstract available

Keywords: Acute coronary syndrome; Bivalirudin; Heparin; Myocardial infarction; Percutaneous coronary intervention.

Publication types